IHE icon

iShares US Pharmaceuticals ETF
IHE

Overview Fund Activity

95 hedge funds and large institutions have $79M invested in iShares US Pharmaceuticals ETF in 2020 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 22 increasing their positions, 28 reducing their positions, and 10 closing their positions.

Holders
95
Holders Change
+3
Holders Change %
+3.26%
% of All Funds
1.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
22
Reduced
28
Closed
10
Calls
$728K
Puts
$3K
Net Calls
+$725K
Net Calls Change
-$304K

Top Buyers

1
CFGS
1
Concourse Financial Group Securities
Alabama
$3.8M
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$7.58M
3
Bank of America
3
Bank of America
North Carolina
$4.63M
4
Wells Fargo
4
Wells Fargo
California
$2.28M
5
FTUS
5
Flow Traders U.S.
New York
$391K

Top Sellers

1
Royal Bank of Canada
1
Royal Bank of Canada
Ontario, Canada
$4.7M
2
Citadel Advisors
2
Citadel Advisors
Florida
$2.37M
3
Stifel Financial
3
Stifel Financial
Missouri
$0
4
SRSA
4
S.R. Schill & Associates
Washington
$0
5
TRCT
5
Tower Research Capital (TRC)
New York
$428K
Name Market Value Shares Shares
Change 		Shares
Change %
EWM
101
Edge Wealth Management
New York
– – -3,327 Closed
FANJ
102
Financial Architects (New Jersey)
New Jersey
– – -1,173 Closed
JPLA
103
Joseph P. Lucia & Associates
New York
– – -780 Closed
BWA
104
BDO Wealth Advisors
Florida
– – -45 Closed
TFA
105
Transamerica Financial Advisors
Florida
– – -3 Closed
HNB
106
Huntington National Bank
Ohio
– – – –
1 2 3 4
5